UiPath vs. AppLovin: Which AI-Driven Tech Stock is Purchase-Worthy?

UiPath (PATH) is identified as the more compelling AI-driven investment compared to AppLovin (APP), despite AppLovin's higher projected growth rates. UiPath maintains leadership in the robotic process automation market, reporting 12% annual recurring revenue growth and strong enterprise partnerships with Microsoft, Amazon, and Salesforce. While AppLovin's Axon 2 AI engine has significantly boosted ad spend on its platform, UiPath's valuation at 4.09X forward sales is substantially more attractive than AppLovin's 19.88X, positioning PATH as a better value play for long-term, enterprise-grade AI exposure.

Analysis

The analysis presents a comparative investment case between UiPath (PATH), a leader in the robotic process automation (RPA) market, and AppLovin (APP), a key player in AI-driven mobile ad technology. UiPath's investment thesis is built on stability and value, underpinned by its strong enterprise partnerships with Microsoft, Amazon, and Salesforce, high customer retention demonstrated by net retention rates between 110-115%, and a robust subscription model driving 12% year-over-year growth in annual recurring revenue to $1.69 billion. In contrast, AppLovin represents a high-growth opportunity, with its Axon 2 AI engine quadrupling advertising spend on its platform and fueling superior projected growth for 2025, with sales expected to rise 16.3% and EPS by 85.4%. The critical differentiator is valuation; PATH trades at a modest 4.09X forward sales, below its 12-month median, whereas APP commands a premium multiple of 19.88X forward sales, above its median. This positions PATH as a value play on enterprise AI adoption, while APP is a momentum play on the recovery and AI-optimization of the mobile ad market.

Key Decisions for Investors

• Investors seeking value-oriented exposure to the AI sector should consider UiPath, given its attractive valuation at 4.09X forward sales, stable recurring revenue model with 12% ARR growth, and strong enterprise partnerships.
• For AppLovin, its high-growth profile, with projected 85.4% EPS growth, is compelling, but investors must be comfortable with its premium valuation of 19.88X forward sales, making it more suitable for portfolios with a higher risk tolerance for momentum stocks.
• The primary consideration is strategic fit: PATH offers a more conservative, enterprise-focused AI investment, whereas APP provides a high-growth, high-multiple play on the monetization of mobile engagement.